LENZ has announced an exclusive licensing and commercialisation agreement with Lotus Pharmaceutical of Taiwan.

The executive order aims to cut US prescription drug costs by linking them to the lowest prices paid internationally.

Isolator lines present several significant advantages for large-scale aseptic filling, as Marcel Langner of IDT Biologika ...

Both the FDA and EMA have suspended Ixchiq’s use in older adults after post-marketing serious adverse events that include two ...

Eli Lilly and Purdue University, US, have announced the widening of their existing partnership with a planned investment of ...

AAN conference featured the latest research and developments in neurological disorders like Alzheimer's disease, epilepsy and ...

Globaldata's analysis focuses on three key indicators, which include HTA outcomes in the 5EU and the entry of newly priced ...

NewBiologix has given a non-exclusive technology licence to Recipharm Advanced Bio to provide pharma companies access to ...

HLS Therapeutics has signed an agreement with Esperion Therapeutics for commercialising Nexletol and Nexlizet in Canada.

Novo Nordisk has cut its sales and profits forecasts for 2025 due to lower demand in the US for blockbuster weight loss and ...

As scientists explore treating genetic disorders before birth, the promise of foetal gene therapy is growing—but there are ...